Folia Histochemica et Cytobiologica, 2011 Abciximab (Abci) and eptifibatide (Epti) are antiaggregate drugs which may reduce thrombotic complications in acute coronary syndromes. The aim of this work was the investigation of the interaction between the phospholipid-GPIIb/IIIa glycoprotein complex
Anna Sankiewicz +2 more
doaj +1 more source
Emergency coronary bypass grafting for failed percutaneous coronary artery stenting: increased costs and platelet transfusion requirements after the use of abciximab [PDF]
, 1998 John M. Alvarez
openalex +1 more source
Terapias emergentes: inhibidores de glicoproteína IIB/IIIA en ataque cerebrovascular agudo
Acta Neurológica Colombiana, 2010 El ataque cerebrovascular (ACV) es una causa común de morbilidad y mortalidad en el mundo. La terapia trom- bolítica con (r-TPA), es la única terapia aprobada para el tratamiento del ACV y esta terapia solo se logra aplicar en el 2 % de los pacientes ...
Juliana Coral Casas
doaj +2 more sources
Heart Views, 2013 Background: In patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty, abciximab reduces major adverse cardiac events (MACE). Most clinical trials have studied mainly intravenous administration.
Mohammed Balghith +3 more
doaj
Attainment and Maintenance of Platelet Inhibition Through Standard Dosing of Abciximab in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary Intervention [PDF]
, 1999 Steven R. Steinhubl +7 more
openalex +1 more source
Administration of Abciximab During Percutaneous Coronary Intervention Reduces Both Ex Vivo Platelet Thrombus Formation and Fibrin Deposition [PDF]
, 1998 George Dangas +8 more
openalex +1 more source
Adjuvant antithrombotic therapy in ST-elevation myocardial infarction: A narrative review
Revista Portuguesa de Cardiologia, 2019 This article reviews the major pharmacologic features of, and clinical evidence on, adjuvant medical therapy in patients with ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention.
Daniel Caldeira, Hélder Pereira
doaj
Adverse Drug Effect Profiles of Gp2b/3a Inhibitors: A Comparative Review of the Last Two Decades. [PDF]
Cureus, 2023 Hasan N +9 more
europepmc +1 more source
Abciximab in Acute Ischemic Stroke [PDF]
, 2000 The Abciximab in Ischemic Stroke Investigators
openalex +1 more source